Treatment Modalities in Children and Adolescents Suffering From HDM-induced Allergic Rhinitis and/or Asthma (PROTECT)
Modalités de Prise en chaRge en Pratique quOTidienne d'Allergologie Des Enfants et/ou adolesCents souffranT d'Allergie Aux Acariens / Treatment Modalities in Allergist Daily Practice in Children and/or Adolescents Suffering From HDM Allergy
Sponsor: Monitoring Force Group
Listed as NCT04004351, this observational or N/A phase trial focuses on Allergy and remains completed. Sponsored by Monitoring Force Group, it has been updated 4 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Aug 2019 — Jan 2021 [monthly]
Completed
First recorded
Sep 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Monitoring Force Group
- Stallergenes Greer
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.